Recall Radar
All recallsMedicine & devices

Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30

Failed Impurities/Degradation Specifications

Class III Medicine & devices FDA July 8, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ
Severity
Class III — low
Reported
July 8, 2026
Quantity
9,048 bottles
Recall number
D-0654-2026
Status
Ongoing
Source
FDA

Where it went

U.S. Nationwide

Other medicine & devices recalls

See every current recall on the live dashboard →